TABLE OF CONTENTS

Background 1

Statement of Policy 1

Program on Drug Free Workplace 2

A. Advocacy, Education and Training 2

B. Mandatory Drug Test 3

C. Treatment, Rehabilitation, and Referral 5

D. Consequences of Policy Violations 6

E. Monitoring and Evaluation 6

F. Confidentiality 8

G. Effectivity 8

Drug-Free Workplace Policy and Program Acknowledgement 8

Notification of Positive Drug Test 9

Directory 10
 THE NATIONAL CONCILIATION AND MEDIATION BOARD
DRUG-FREE WORKPLACE POLICY AND PROGRAM

In keeping with Republic Act 9165 otherwise known as the

Comprehensive Dangerous Drugs Act of 2002, and its Implementing Rules and
Regulations and as part of our commitment to safeguard the wellbeing of our
employees and to provide a safe environment for everyone, the National
Conciliation and Mediation Board (NCMB) hereby establishes a drug-free
workplace policy and program.

STATEMENT OF POLICY

The NCMB is committed to create and maintain a drug-free workplace

towards a safe, productive, and drug-free environment.

Thus, the following are explicitly prohibited:

1. Use, possession, solicitation for, or sale of dangerous drugs on the

Board’s premises or while on official field work or travel;

2. Being impaired or under the influence of dangerous drugs away from the
Board, even if such impairment or influence does not adversely affect the
employee's work performance, the safety of the employee or of others,
or puts at risk NCMB’s reputation; and

3. The presence of any detectable amount of dangerous drugs in the

employee's system while at work, while on the premises of the Board, or
while on official business. "Dangerous Drugs" include those listed in the
1 IPage
 Schedules annexed to the 1961 Single Convention on Narcotic Drugs, as
amended by the 1972 Protocol, and in the Schedules annexed to the
1971 Single Convention on Psychotropic Substances as enumerated in
the attached annex of R.A. 9165.

PROGRAM ON DRUG-FREE WORKPLACE

A. ADVOCACY, EDUCATION AND TRAINING

1. NCMB undertakes to increase the awareness and education of its

officials and employees on the adverse effects of dangerous drugs
through continuous advocacy, education, and training
programs/activities to all its officers and employees.

2. All officials and employees are required to undergo an

orientation/education program which shall include the following topics:

 Salient features of R.A. 9165;

 Adverse effects of abuse and/or misuse of dangerous
drugs on the person, workplace, family and the
community;
 Preventive measures against drug abuse; and
 Steps to take when intervention is needed, as well as
available services for treatment and rehabilitation.

3. The Board shall ensure that the workplace policies and programs on
the prevention and control of dangerous drugs, including drug testing,
shall be disseminated to all officers and employees. The employer
shall obtain a written acknowledgement from the employees that the
policy has been read and understood by them.

2 IPage
A. MANDATORY DRUG TEST

1. In consonance with the Civil Service Commission (CSC)

Memorandum Circular (MC) No. 34, s. 1997, all new entrants to
government service through the NCMB shall be required to undergo
mandatory drug test, the results of which shall be submitted to the
Board and form part of the 201 file of the employee concerned. Thus,
the conduct of mandatory drug test is part of the basic requirements
for employment.

2. All Officials and employees may be selected at random for drug testing
at a period determined by the Board.

3. Any official or employee shall be required to submit to reasonable-

suspicion drug testing. Reasonable-suspicion drug testing is drug
testing based on a belief that an employee is using or has used drugs
in violation of the drug-free workplace policy. Reasonable suspicion
may be drawn from specific objective and articulable facts and
reasonable inferences drawn from those facts in light of experience.
Among other things, such facts and inferences may be based upon:

 Observable phenomena while at work, such as direct

observation of drug use or of the physical symptoms or
manifestations of being under the influence of a drug;

 Abnormal conduct or erratic behavior while at work or a

significant deterioration in work performance;

 A report of drug use, provided by a reliable and credible source;

 Evidence that an individual has tampered with a drug test

during his or her employment with the current employer; or

3 IPage
  Evidence that an employee has used, possessed, sold,
solicited, or transferred drugs while working or while on the
Board’s premises or while operating official vehicle, machinery,
or equipment.

4. All drug tests shall use the following testing methods:

 Screening test which will determine the positive result as well

as the type of the drug used; and

 Confirmatory test which will confirm a positive screening test. If

the confirmatory test turns positive, the Board’s Drug-free
Workplace Team shall determine the administrative
interventions that can be extended to the employee concerned.

5. All drug tests of NCMB Central Office and Regional Conciliation and
Mediation Branch-National Capital Region (RCMB-NCR) shall be
conducted by East Avenue Medical Center. The rest of the RCMBs
shall coordinate with the regional offices of the Department of Health
in the selection of the hospital or drug testing center in their respective
regions.

6. NCMB shall inform the official/employee who was subjected to a drug

test of the test-results whether positive or negative.

7. All costs of drug testing shall be borne by the Board.

8. Refusal to submit to mandatory drug testing shall be a valid ground for

dismissal from the service.

9. While the Board understands that employees and applicants under a

physician’s care are required to use prescription drugs, abuse of the
same shall be dealt with in the same manner as the abuse of illegal
substances.

4 IPage
B. TREATMENT, REHABILITATION, AND REFERRAL

1. An official/employee who, for the first time, is found positive of drug

use, shall be referred for treatment and/or rehabilitation in a DOH
accredited center. For this purpose, the Board shall provide a list of at
least three (3) accredited facilities which an employee who was tested
positive for drugs may choose from.

2. Following rehabilitation, the Board’s Drug-free Workplace Team, in

consultation with the head of the rehabilitation center, shall evaluate
the status of the drug dependent official/employee and recommend to
the Board the resumption of the employee’s job if he/she poses no
serious danger to his/her co-employees and/or the workplace.

3. All costs for the treatment and rehabilitation of the drug dependent
employee shall be charged to his/her account. The period during
which the official/employee is under treatment or rehabilitation shall
be considered as authorized leaves.

4. Repeated drug use even after ample opportunity for treatment and
rehabilitation shall be dealt with the corresponding penalties under
R.A. 9165 and is a ground for dismissal.

5 IPage
C. CONSEQUENCES OF POLICY VIOLATIONS

Any official or employee who uses, possesses, distributes, sells or

attempts to sell, tolerates, or transfers dangerous drugs or otherwise
commits other unlawful acts as defined under Article II of RA 9165 and
its Implementing Rules and Regulations shall be subject to the pertinent
provisions of the said Act.

D. MONITORING AND EVALUATION

The implementation of these policies and programs shall be

monitored and evaluated periodically by the Board’s Drug-free Workplace
Team management to ensure a drug-free workplace.

6 IPage
 E. CONFIDENTIALITY

All information, reports, statements, memoranda, and drug test

results, written or otherwise, received or produced as a result of this drug-
testing program are confidential and may not be used or received in
evidence, or disclosed in any public or private proceedings. Exceptions
may be made only where required by law, in case of overriding public
health and safety concerns; or where such exceptions have been
authorized in writing by the person concerned.

F. EFFECTIVITY.

The provisions of these policies and programs shall be immediately

effective fifteen days after dissemination to all officials and employees of
the Board.

Approved by:

SHIRLEY M. PASCUAL, CESO III

Executive Director IV

23 May 2017
mtdlcancio

7 IPage
 Drug-Free Workplace Policy and Program
Acknowledgement
I hereby acknowledge that I have received and read the National Conciliation
and Mediation Board Drug-Free Workplace Policy and Program. I understand
that I must abide by it as a condition of initial and/or continued employment, and
any violation may result in disciplinary action up to and including termination.

I also understand that during my employment I may be required to submit to

testing for the presence of drugs in my body. I understand that submission to
such testing is a condition of employment with the Board, and disciplinary action
up to and including termination may result if:

1) I refuse to consent to testing.

2) I refuse to execute all forms of consent and
release of liability that are usually and
reasonably associated with such examinations.
3) I refuse to authorize release of the test results
to the Board.
4) The tests establish a violation of the Board’s
Drug-Free Workplace Policy.
5) I otherwise violate the policy.

I also recognize that the Drug-Free Workplace Policy and Program and related
documents are not intended to constitute a contract between the NCMB and
me.

The undersigned further states that he/she has read and understands the
above acknowledgement and signs below of his/her own free will.

_____________________________ ______________________
SIGNATURE DATE

___________________________ ________________________
WITNESS DATE

8 IPage
 NOTIFICATION OF POSITIVE DRUG TEST

Dear _____________________:

On ____________, you were drug tested according to requirements in the

National Conciliation and Mediation Board Drug-Free Workplace Policy and
Program. Based on the drug testing standards, your urine/blood specimen was
tested twice in a controlled laboratory environment, which includes confirmation
testing.

We have received the drug test result from ______________________, and the
result indicates that you have tested positive (failed the test) for the following
substance(s):

______ Cannabinoids (marijuana) ______ Amphetamines

______ Cocaine
______ Phencyclidine (PCP) ______ Methaqualone
______ Opiates ______ Barbiturates
______ Benzodiazepines ______ Synthetic Narcotics

In keeping with the Board’s Drug-Free Workplace Policy and Program, the
following disciplinary procedure(s) will take place immediately:

______________________________________________________________

______________________________________________________________

______________________________________________________________

If you disagree with the test result or have some other related concern, you have
the right to submit information explaining or contesting the test result, and
explaining why the positive test result does not constitute a violation of our Drug-
Free Workplace Policy and Program, within five working days after receiving
this notice.

Very truly yours,

________________

9 IPage
 DIRECTORY
NATIONAL CONCILIATION AND MEDIATION BOARD
CENTRAL OFFICE
th th
4 –6 Floors, Arcadia Building, 860 Quezon Avenue, Quezon City

SHIRLEY M. PASCUAL, CESO III CORAZON M. FEGI

Executive Director IV Chief, Voluntary Arbitration Division
(02) 332-4176, 332-4175(telefax) (02) 332-4178
ncmbco@yahoo.com ncmb_vad@yahoo.com

EDMUNDO T. MIRASOL ROSE-MARIA C. MAMAOAG

Deputy Executive Director IV Officer-In-Charge
(02) 332-2689, 332-4177 Administrative Division
ncmbco@yahoo.com 332-4180
ncmb_admin@yahoo.com
MARIA TERESITA L. CANCIO
Deputy Executive Director IV EDITHLIANE P. TADEO
(02) 332-4179 (telefax) Chief, Financial Management
ncmbco@yahoo.com Division
332-2231
ATTY. RONDA D. MALIMBAN ncmb_fmd@yahoo.com
Director II, Technical Services
(02) 332-2233 MARIFE E. FAUSTO
ncmbco@yahoo.com Officer-In-Charge
Research and Information Division
MARIA CRISTINA O. MANGALIMAN 332-2232
Director II, Internal Services ncmbco@yahoo.com
(02) 412-5148
ncmbco@yahoo.com NENITA L. IMPERIAL
Auditor
MA. YOLANDA P. MIÑORIA Commission on Audit
Officer-In-Charge 410-8932
Conciliation-Mediation Division
(02) 332-2209
ncmb_cmd@yahoo.com

LOVELYN S. PAPAS
Chief, Workplace Relations Enhancement Division
(02) 415-7888

10 I P a g e
 DIRECTORY
REGIONAL BRANCHES

TERESITA E. AUDEA EDGAR G. AQUINO

Director II, RCMB – NCR Director II, RCMB III
Ground Floor, DOLE Building, 2nd Floor, PSP Building, Gapan-
Intramuros, Manila 1002 Olongapo Road, Dolores
527-72-16; 526-42-30 telefax San Fernando, Pampanga 2000
Conciliation-Mediation Unit (045) 961-42-64 (t/ fax)
301-00-48 to 51 (045) 963-7868
ncmbsanfernando@yahoo.com
Voluntary Arbitration Unit
310-9545 FELICIANO R. ORIHUELA, JR.
Director II, RCMB IV-A
Workplace Relations and (049) 531-4271; (049) 531-2045
Enhancement Unit 310-2441 2/F Regon and Sons Building,
Administrative Unit 310-24-42 National Road, Paciano Rizal,
Commission on Audit 527-35-73 Calamba City, Laguna 4027
ncmbiva@yahoo.com
BRENDA ROSE C. ODSEY
Director II, RCMB – Cavite Extension Office
Cordillera Administrative Region 2/F MYP GBY Building
(074) 442-7292 (t/ fax) Bayan Luma 7
3/F Manongdo Bldg., Benitez Court Aguinaldo Highway
Magsaysay Avenue, Baguio City 2600 Imus, Cavite
ncmbcar@yahoo.com (046) 476-0807
(046) 471-0615
LUCITA D.O. CAUDILLA
ncmbiva@yahoo.com
Officer-In-Charge, RCMB I
(072) 888-4610 (t/ fax)
Cainta Extension Office
2nd Floor, Unison Realty Building
2nd Floor, F. Takano Center for
Quezon Avenue, City of San Fernando
Health
La Union ncmbr_b1@yahoo.com.ph
Cainta, Rizal
GIL G. CARAGAYAN (02) 656-5213
Director II, RCMB II ncmbiva@yahoo.com
(078) 844-1356
3/F, CRADDOCK Bldg., Diversion Road LOURDES P. ESTIOCO
San Gabriel Village, Tuguegarao City 3500 Director II, RCMB IV-B
rcmb02@yahoo.com (02) 400-2529
G/F, DOLE Building General Luna
cor
Muralla Streets Intramuros, Manila
rcmb4b@gmail.com

11 I P a g e
 DIRECTORY
REGIONAL BRANCHES

REYNALDO S. FONCARDAS ROGEN S. CUMBA

Director II, RCMB V Director II, RCMB IX
(052) 480-8467 (t/ fax) (062) 991-2644; (062) 991-2186
2nd Floor, ANST Building 3rd Floor, Wee Agro Building
Washington Drive, Legaspi City 4500 Veterans Ave., Zamboanga City 7000
ncmbrb5@yahoo.com ncmbr9@yahoo.com
ATTY. LIGAYA R. LUMBAY
ROSEMARIE G. OXINIO Officer-in-Charge, RCMB X
Officer-in-Charge, RCMB VI (088) 856-61-23; (088) 881-3123
District Office 2nd Floor, Room 202 Maguindanao Masonic Temple
Viosil’s Building, M.H. Del Pilar, Building
Molo, Iloilo City Capistrano-Pacana Street,
(033) 332-2199; 0917-3054347 Cagayan de Oro City 9000
ncmbrb6@yahoo.com northmin_rcmb@yahoo.com

SUSANA A. QUIMPO AERRINE MARIE R. REYES

Director II, Negros Island Region Officer-in-Charge, RCMB XI
No. 6, 10th Lacson Streets Milagros (082) 226-3465 (t/fax) (082) 295-7083
Building, Bacolod City 6100 DCPI Building, Quezon Boulevard
(034) 433-0901; 0917-3023412 Brgy. 31 Davao City 8000
ncmbrb11@yahoo.com
GEMMA R. POLOYAPOY GERIE D. LAMPITCO
Officer-in-Charge, RCMB VII Officer-in-Charge, RCMB XII
(032) 415-7046 (032) 230-7909 (083) 228-3438
(032) 266-8194 (PLDT) (032) 266-8193 Door #1 Mezzanine Floor, Duremdes
6th Floor, Old Insular Life Building Building, Zone 1, Gensan Drive,
Gen. Maxilom Avenue cor. Gorordo Avenue, Koronadal City, South Cotobato
Cebu City 6000
cebu.ncmb@yahoo.com 2nd Floor, Dimalanta Building,
Leopoldo D. Dacera Sr. Avenue
GEMMA R. POLOYAPOY (Concurrent) (formerly Mabuhay Road)
Officer-In-Charge, RCMB VIII Brgy. City Heights, Gen Santos City
(053) 832-0659 (083) 552-5758
DOLE Compound, Trece Martirez Street, ncmbrb12@yahoo.com.ph
Tacloban City 6500
MA. THERESA M. FRANCISCO
ncmbrb8@yahoo.com
Officer-in-Charge, RCMB XIII
(085) 342-5871 (t/ fax) 342-9131
1st & 2nd Floors, Nimfa Tiu Building,
J.P. Rosales Street, Butuan City
ncmb13caraga@yahoo.com

12 I P a g e